Arbutus Biopharma (ABUS) vs Olema Pharmaceuticals (OLMA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Arbutus Biopharma (ABUS) has outperformed Olema Pharmaceuticals (OLMA) over the past year, gaining 0.0% versus a loss of 23.9%. Over five years, ABUS leads with a +5.1% price change compared with -74.1% for OLMA. Olema Pharmaceuticals is the larger company by market cap ($694.7 million vs $657.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABUS | OLMA |
|---|---|---|
| Share price | $4.29 | $7.94 |
| Market cap | $657.55M | $694.73M |
| 1-day change | -4.24% | +0.25% |
| YTD return | -10.81% | -68.24% |
| 1-year return | 0.00% | -23.95% |
| 5-year return | +5.15% | -74.15% |
| P/E ratio (TTM) | 5.43 | — |
| EPS (TTM) | $0.79 | $-2.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.45 | $36.26 |
| 52-week low | $3.50 | $6.65 |
| Distance from 52-week high | -21.28% | -78.10% |
| Average volume | 4.68M | 1.07M |
| Shares outstanding | 153.28M | 87.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ABUS has outperformed OLMA by 23.9 percentage points over the past year.
ABUS vs OLMA FAQ
Which is bigger, Arbutus Biopharma or Olema Pharmaceuticals?
Olema Pharmaceuticals (OLMA) is larger, with a market capitalization of $694.73M compared with $657.55M for Arbutus Biopharma (ABUS).
Which stock has performed better over the past year, ABUS or OLMA?
ABUS returned 0.00% over the past 12 months, compared with -23.95% for OLMA (price return, excluding dividends). Past performance does not predict future results.
Are Arbutus Biopharma and Olema Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.